Navar, A. M., Mulder, H. M., Wojdyla, D. M., & Peterson, E. D. (2020). Have the Major Cardiovascular Outcomes Trials Impacted Payer Approval Rates for PCSK9 Inhibitors? Circ Cardiovasc Qual Outcomes.
Chicago ZitierstilNavar, Ann Marie, Hillary M. Mulder, Daniel M. Wojdyla, und Eric D. Peterson. "Have the Major Cardiovascular Outcomes Trials Impacted Payer Approval Rates for PCSK9 Inhibitors?" Circ Cardiovasc Qual Outcomes 2020.
MLA ZitierstilNavar, Ann Marie, Hillary M. Mulder, Daniel M. Wojdyla, und Eric D. Peterson. "Have the Major Cardiovascular Outcomes Trials Impacted Payer Approval Rates for PCSK9 Inhibitors?" Circ Cardiovasc Qual Outcomes 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.